M. Hilding et al., Clodronate prevents prosthetic migration - A randomized radiostereometric study of 50 total knee patients, ACT ORTH SC, 71(6), 2000, pp. 553-557
Citations number
26
Categorie Soggetti
Ortopedics, Rehabilitation & Sport Medicine","da verificare
In a double-blind study, Ne randomized 50 patients to receive peroral clodr
onate medication or placebo from 3 weeks before until 6 months after a tota
l knee replacement with a cemented NexGen implant. Migration of the tibial
components was measured by radiostereometry at 1 year. Clodronate reduced p
rosthetic migration, as measured by maximum total point motion, from 0.40 m
m to 0.29 mm (p = 0.01). This confirms that the early postoperative migrati
on is related to bone resorption and thus the biology of the bone bed. Sinc
e early migration is related to late loosening, 6 months of clodronate medi
tation might reduce the risk of loosening.